• Home/
  • News/
  • 4 More Indian Pharma Firms Expected To Start COVID Vaccine Production By October-November: Union Health Minister

News

4 More Indian Pharma Firms Expected To Start COVID Vaccine Production By October-November: Union Health Minister

The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will help meet the domestic demand, said Union Health Minister Mansukh Mandaviya

4 More Indian Pharma Firms Expected To Start COVID Vaccine Production By October-November: Union Health Minister
Highlights
  • Vaccination drive is going on smoothly, said Union Health Minister
  • COVID vaccination in India is likely to get a boost in the coming days
  • India has administered 47 crore COVID vaccine doses so far

New Delhi: Union Health Minister Mansukh Mandaviya on Tuesday (August 3) said in Parliament that four more Indian pharma firms are expected to start anti-coronavirus vaccine production by October-November that will accelerate the inoculation drive. During the Question Hour in the Rajya Sabha, Mr Mandaviya said India has administered 47 crore doses of vaccine so far and the Centre is making efforts to inoculate the entire country at the earliest. Even 7 to 9 per cent of the doses that remain unutilised by private hospitals are being used by the government vaccination centres, he added.

Also Read: What Is A Breakthrough Infection And How To Prevent Catching COVID-19 After Getting Fully Vaccinated

Mr Mandaviya was speaking amid a din in the house over the Opposition’s demand for a discussion on the Pegasus issue and the farm laws.

Vaccination drive is going on smoothly… It will get more accelerated in the coming days with the ramping up of production by four more Indian companies, the minister said.

The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will help meet the domestic demand, he said. Biologicals E and Novartis vaccines will also be available in the market in the coming days, while Zydus Cadila will soon get an emergency-use nod from an expert committee, the Union Health Minister said. At present, two companies (Bharat Biotech and Serum Institute) are supplying the vaccine to the government. Sputnik vaccine is also available and production of which has begun, he added.

Also Read: Will Third Wave Be Severe? When Can Children Get COVID-19 Vaccine? AIIMS Chief Dr Randeep Guleria Tells NDTV

To a query by BJD member Amar Patnaik about the vaccine rollout plan for 12-18-year-old and the need for a third or fourth dose, Mr Mandaviya said,

The government’s target is to vaccinate the entire population at the earliest and constant efforts are being made to achieve this.

Unlike BCG (bacille Calmette-Guerin) and polio vaccines that came to India much later after its launch in other parts of the world, the vaccine against coronavirus was made available in India at the same time in the world due to the efforts of the Narendra Modi government, he said The prime minister took steps, supported scientists and companies to ensure vaccines were available in the country at the earliest, the minister said.

Also Read: Monthly Production Capacity Of Covishield Projected To Increase To 120 Million Doses, Covaxin To 58 Million Doses: Government

Thus vaccination drives began in India which has administered 47 crore doses so far, the maximum in the world. We are going to accelerate it further in the coming days, he said.

Responding to BJP member Susheel Kumar Modi’s query on the government’s plan to reduce the vaccine quota to private hospitals, the minister said it was not necessary as the unused vaccine quota of the private hospitals is taken by the government.

In a month, we saw seven to nine per cent unused vaccines by private hospitals. So, we decided to take those unutilised doses in the government quota. Therefore, it is not necessary to reduce the quota for the private. The vaccination is happening smoothly, he said.

The Centre is buying 75 per cent of the vaccine produced to give free jabs to people, while 25 per cent is allocated for the private sector, the health minister added.

Also Read: Made In India Sputnik V To Be Available During September- October: Dr Reddy’s

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

[corona_data_new]
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *